Form 4: Director Gillin Elects Stock for Compensation

Leslie Gillin, a Director at Establishment Labs Holdings Inc., received 411 common shares in lieu of a cash retainer payment.

Summary

• Director Leslie Gillin acquired 411 common shares of Establishment Labs Holdings Inc. (ESTA).
• The shares were acquired on September 30, 2025, at a price of $40.99 per share.
• This acquisition represents common shares elected by Ms. Gillin to be received instead of a quarterly cash retainer payment.
• The transaction was made in accordance with the Issuer's Outside Director Compensation Policy and pursuant to the Issuer's 2018 Equity Incentive Plan.
• Following this transaction, Ms. Gillin directly beneficially owns 15,516 common shares.

Sentiment

Score: 7

Explanation: The transaction is a routine director compensation event where a director elected to receive shares instead of cash, indicating alignment of interests with shareholders. It does not reflect significant operational news but is a positive signal regarding director commitment.

Positives

• Director Leslie Gillin's election to receive shares instead of cash demonstrates alignment of her interests with shareholders.
• The issuance of shares under the 2018 Equity Incentive Plan indicates the company's use of equity-based compensation to retain and incentivize directors.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance beyond the transaction details.

Industry Context

This transaction reflects a common practice in corporate governance where directors elect to receive equity compensation, aligning their financial interests with the long-term performance of the company. This is a standard mechanism for director remuneration in many publicly traded companies, particularly in the medical technology or healthcare sector where Establishment Labs operates.

Comparison to Industry Standards

• The practice of compensating directors with equity, such as common shares in lieu of cash, is a widely accepted corporate governance standard across various industries, including medical devices and biotechnology. Companies like Medtronic plc (MDT) and Johnson & Johnson (JNJ) also utilize equity-based compensation plans for their non-employee directors to foster alignment with shareholder interests.
• The specific valuation method, using the closing price on the last trading day of the quarter, is a common and transparent approach for determining the number of shares granted in such compensation schemes.

Corporate Governance

Related Party Transactions

• Director Leslie Gillin, a related party, received 411 common shares in lieu of a cash retainer payment, as per the company's Outside Director Compensation Policy.

Stakeholder Impact

• Shareholders: Increased alignment of director interests with long-term shareholder value through equity ownership.
• Directors: Provides flexibility in compensation structure, allowing directors to choose between cash and equity.

Key Dates

Recommendation

This Form 4 filing reports a routine director compensation event where a director elected to receive shares instead of cash. While it signals director alignment, it does not provide new material information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

Establishment Labs Holdings Inc., ESTA, Leslie Gillin, Director Compensation, Equity Incentive Plan, Insider Ownership, Form 4, Stock Grant